Market Research Logo

Spain Pharmaceuticals & Healthcare Q3 2018

Spain Pharmaceuticals & Healthcare Q3 2018

BMI View:

The Spanish government will remain committed fiscal consolidation, targeting the healthcare sector and prescriptiondrug expenditure in particular, as it faces considerable pressure from rising healthcare costs. Spain’s out-of-pocket expenditure onhealth is well above the EU average, a result of health reforms which shifted some of the costs for healthcare and medicine ontohouseholds. These trends, combined with the forecasted economic slowdown in the coming years, will limit revenue earningopportunities for multinational drugmakers operating in the country.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Forecast
Patented Drug Forecast
Generic Drug Forecast
OTC Medicine Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
Spain Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report